BSC
BIO icon

BOLTON SECURITIES CORPORATION’s Bio-Rad Laboratories Class A BIO Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.7K Buy
+67
New +$19.3K ﹤0.01% 1475
2025
Q3 		$18.8K Buy
+67
New +$18.2K ﹤0.01% 1400
2025
Q1 		$16.3K Buy
+67
New +$20.2K ﹤0.01% 1329

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Ariel Investments
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $25.4B AUM 35.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's BIO Position: Q1 2026 in Review

BOLTON SECURITIES CORPORATION opened a new position in Bio-Rad Laboratories Class A (BIO) in Q1 2026: 67 shares worth $18.7K. The stake represents ﹤0.01% of the portfolio and ranks #1475 among its holdings. This is a return to the name: BOLTON SECURITIES CORPORATION previously reported a position in BIO as recently as Q3 2025.

BOLTON SECURITIES CORPORATION first reported a position in BIO in Q1 2025 and has held it in 3 quarters since. The position peaked at $18.8K in Q3 2025. 399 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • BOLTON SECURITIES CORPORATION held 67 shares of Bio-Rad Laboratories Class A worth $18.7K as of Q1 2026.
  • Bio-Rad Laboratories Class A was a new BOLTON SECURITIES CORPORATION position in Q1 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2026, its #1475 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Bio-Rad Laboratories Class A in Q1 2025 and has held it in 3 quarters since.
  • BOLTON SECURITIES CORPORATION's Bio-Rad Laboratories Class A position peaked at $18.8K in Q3 2025.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2026, filed 12 Nov 2026.